Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion

  • Zheng-sheng Wu1, 2,
  • Chao-qun Wang1, 3,
  • Ru Xiang1,
  • Xue Liu1,
  • Shan Ye1,
  • Xue-qing Yang1,
  • Gui-hong Zhang1,
  • Xiao-chun Xu1, 4,
  • Tao Zhu5 and
  • Qiang Wu1, 6Email author
Contributed equally
BMC Cancer201212:51

DOI: 10.1186/1471-2407-12-51

Received: 9 July 2011

Accepted: 1 February 2012

Published: 1 February 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
9 Jul 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
1 Aug 2011 Reviewed Reviewer Report - Naohiko Seki
1 Aug 2011 Reviewed Reviewer Report - Hailong Wu
9 Aug 2011 Reviewed Reviewer Report - Junfang Ji
6 Nov 2011 Author responded Author comments - Zhengsheng Wu
Resubmission - Version 3
6 Nov 2011 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
8 Nov 2011 Reviewed Reviewer Report - Junfang Ji
13 Nov 2011 Reviewed Reviewer Report - Naohiko Seki
23 Nov 2011 Reviewed Reviewer Report - Hailong Wu
27 Dec 2011 Author responded Author comments - Zhengsheng Wu
Resubmission - Version 5
27 Dec 2011 Submitted Manuscript version 5
Publishing
1 Feb 2012 Editorially accepted
1 Feb 2012 Article published 10.1186/1471-2407-12-51

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Pathology, Anhui Medical University
(2)
Department of Pathology, Shanghai Medical College, Fudan University
(3)
Department of Pathology, Dongyang People's Hospital
(4)
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center
(5)
School of Life Science, University of Science and Technology of China
(6)
Department of Pathology, Anhui Medical University

Advertisement